Skip to content

Clinical trials

Respiratory Distress Syndrome trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Country / region: Saudi Arabia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20141
20201
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Canadian Critical Care Trials Group2
AstraZeneca1
Australian and New Zealand Intensive Care Research Centre1
King Abdul Aziz Specialist Hospital1
King Abdullah International Medical Research Center1
Ministry of Health, Saudi Arabia1
Prince Sattam Bin Abdulaziz University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome8
Ventilator-Induced Lung Injury2
COVID-191
Coronavirus Infections1
Hyaline Membrane Disease1
Infections1
Influenza, Human1
Lung Diseases1
Premature Birth1
Respiratory Tract Infections1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.